logo

For the Inventor, By the Inventor

New York, NY, United States of America

In Jong Kim

This inventor holds 4 USPTO granted patents. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1998-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: In Jong Kim. Retrieved from https://idiyas.com/inventor/in-jong-kim-vla0xrte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Seoul, KR (2001)
  • New York, NY (US) (1998 - 2003)

Company Filing History:

goldMedal4 out of 519 
 
Sloan-Kettering Institute for Cancer Research
 patents

Years Active: 1998-2003

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6544952 - Synthesis of glycoconjugates of the globo-H epitope and uses thereof (2003-04-08),
2. 6238668 - Colon cancer KH-1 and N3 antigens (2001-05-29),
3. 6090789 - Synthesis of the breast tumor-associated antigen defined by monoclonal (2000-07-18),
4. 5708163 - Synthesis of the breast tumor-associated antigen defined by (1998-01-13),

Title: In Jong Kim: Innovator in Cancer Research

Introduction

In Jong Kim is a prominent inventor based in New York, NY (US), known for his significant contributions to cancer research. He holds a total of 4 patents, showcasing his innovative approaches in the field of oncology.

Latest Patents

One of his latest patents is focused on the synthesis of glycoconjugates of the globo-H epitope and their uses in colon cancer. This invention provides processes for the preparation of the KH-1 and N3 antigens, along with related analogues that are useful as anticancer therapeutics. The invention also details various intermediates useful in the preparation of KH-1 and N3 and their analogues. Additionally, it offers various compositions comprising any of the analogues of KH-1 and N3, which are available through the methods of the invention, along with pharmaceutical carriers useful in treating subjects suffering from various forms of epithelial cancer.

Career Highlights

In Jong Kim is affiliated with the Sloan Kettering Institute for Cancer Research, where he continues to advance his research and innovations in cancer therapeutics. His work has been instrumental in developing new strategies for cancer treatment.

Collaborations

He has collaborated with notable colleagues in the field, including Samuel J. Danishefsky and Philip O. Livingston, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

In Jong Kim's contributions to cancer research through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in cancer therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…